Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Natura &Co posts another quarter of constant currency sales growth and adjusted…
Natura &Co posted Q2 consolidated net revenue of R$ 7.8 billion, up 1.9% at constant currency (-4.1% in BRL), driven by solid constant currency (CC) growth at Natura &Co Latam. Gross margin was 65.4%, up 430 bps vs Q2-22, and adjusted EBITDA margin was 9.7%, up 230 bps vs the same period last year, reflecting improving margins at all three business units, Natura &Co Latam, Avon International and The Body Shop, as well as a 5.7% drop in corporate expenses. Net income was R$ (732)…
PR Newswire
15/08/2023
Multiple Myeloma Market to Observe Impressive Growth at a CAGR of ~5% During the…
Key Takeaways from the Multiple Myeloma Market Report Key Takeaways from the Multiple Myeloma Market Report Discover which therapies are expected to grab the major multiple myeloma market share @Multiple Myeloma Market Report Multiple Myeloma Overview Multiple myeloma is a type of cancer that affects plasma cells, which are a vital component of the immune system. These plasma cells, normally responsible for producing antibodies to fight infections, become malignant and...
PR Newswire
14/08/2023
Intravenous Equipment Market to Reach $26.7 Billion, Globally, by 2032 at 5.9%…
Request Sample of the Report on Intravenous Equipment Market Forecast 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/11221 Request Sample of the Report on Intravenous Equipment Market Forecast 2032- Allied Market Research-https://www.alliedmarketresearch.com/request-sample/11221 Prime determinants of growth Increase in prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer and autoimmune disorders, technological...
PR Newswire
14/08/2023
Industrial Cooling Systems Market to Reach $31.3 Billion, Globally, by 2032 at…
Download PDF Sample @ https://www.alliedmarketresearch.com/request-sample/12816 Download PDF Sample @https://www.alliedmarketresearch.com/request-sample/12816 Prime determinants of growth The global Industrial cooling systems market is driven by development of the pharmaceutical sector, upgrading cold storage infrastructure across emerging economies, and rise in adoption of energy-efficient & eco-friendly refrigerants. Due to rapid expansion and upgrades in cold storage...
PR Newswire
14/08/2023
TB Alliance Announces Partnership with Remington Pharmaceuticals to…
"TB Alliance is proud to partner with a leading healthcare solutions company in Pakistan to help ensure this treatment is available and accessible to those who need it throughout the country," said Mel Spigelman, President and CEO of TB Alliance. "This exciting update ensures an affordable and sustainable market for state-of-the-art therapies for drug-resistant TB in Pakistan." "TB Alliance is proud to partner with a leading healthcare solutions company inPakistanto help…
PR Newswire
14/08/2023
Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral…
Lead Asset KET01, an Oral Prolonged-Release Ketamine Formulation, Demonstrated Early Improvements in Depressive SeverityKey Findings Included Minimal Incidences of Dissociation or Cardiovascular Effects MUNICH, Germany, Aug.14, 2023(GLOBE NEWSWIRE) -- Ketabon, a joint venture betweenHMNC Brain HealthandDevelco Pharma, announced today top-line results from its Phase 2 KET01-02 Ketabon study with lead asset KET01. KET01 is an oral adjunctive treatment featuring a...
Nasdaq GlobeNewswire
14/08/2023
IM Cannabis Reports Second Quarter 2023 Financial Results
The full set of consolidated financial statements for the three and six months endedJune 30, 2023(the " Q2 FS "), and the accompanying management's discussion and analysis (the " Q2 MD&A "), can be accessed by visiting the Company's website at https://investors.imcannabis.com/, its profile pages on SEDAR+ at www.sedarplus.ca, and EDGAR at www.sec.gov. Q2 2023 Financial Highlights Management Commentary "In Q2 2023, we continued towards our goal of...
PR Newswire
14/08/2023
Copeland Applauded by Frost & Sullivan for Enabling Data Protection, Privacy…
Get access to more details on Copeland's awards page: https://best-practices.frost.com/?page_id=10747&preview=true Get access to more details on Copeland's awards page: https://best-practices.frost.com/?page_id=10747&preview=true Copeland offers smart thermostats under its Sensi brand that solve customers' concerns, enabling them to secure energy savings and protect their data. Its solid focus on respecting users' privacy is an excellent selling point, as its smart thermostats do...
PR Newswire
14/08/2023
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for…
Enrollment and dosing ongoing in registrational study of SerpinPC for the treatment of hemophilia BEnrollment and dosing ongoing in Phase 1/2a Study of LB101, a PD-L1xCD47 LockBody ®for the treatment of solid tumors IND-enabling activities advancing for ORX750, an oral selective orexin receptor 2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; Announces ORX750 preclinical data to be presented at World Sleep Congress in October 2023 Nominates...
Nasdaq GlobeNewswire
14/08/2023
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and…
$24.4 million in cash, cash equivalents and marketable securities as of June 30, 2023 provides projected runway into H2 2024 $24.4 millionin cash, cash equivalents and marketable securities as ofJune 30, 2023provides projected runway into H2 2024 Strengthened financial position with a successfulUS$15 millionpublic offering onAugust 8, 2023 Management hosting conference call and webcast today at8:30 a.m. ET SAN DIEGOandCALGARY, AB,Aug. 14, 2023...
PR Newswire
14/08/2023
XRP Healthcare (XRPH) Will Be Listed On Global Crypto Exchange LBank August 16th…
XRP Healthcare - The first Pharma and Healthcare platform to be built on the XRP Ledger is an innovative, scalable solutions company utilizing Web3 technology to revolutionize the way people access and afford healthcare services globally. XRP Healthcare- The first Pharma and Healthcare platform to be built on the XRP Ledger is an innovative, scalable solutions company utilizing Web3 technology to revolutionize the way people access and afford healthcare services globally. XRP Healthcare...
PR Newswire
14/08/2023
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal…
MAINZ, Germany, August 14, 2023– BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced that the Supervisory Board has appointed James Ryan, Ph.D., to the Management Board as Chief Legal Officer (CLO), effective September 1, 2023. As part of the Management Board, James Ryan will continue to lead the Company's corporate legal strategy and global legal operations including transactions, corporate governance, securities, intellectual property (IP), insurance, data privacy, among...
Nasdaq GlobeNewswire
14/08/2023
Notice of Nexstim Plc's Half-Yearly Report H1 2023
Press release ,Helsinki,14 August2023 at1 PM(EEST) Noticeof NexstimPlc's Half-Yearly Report H1 2023 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") will publish its half-yearly report for the six months ended 30 June 2023 on Friday 18 August 2023 at approximately 9:00 am Finnish time.The company will hold two live webinars for media, investors, and analysts on Friday 18 August 2023. CEO Mikko Karvinen and CFO Joonas Juokslahti will present the financial...
Nasdaq GlobeNewswire
14/08/2023
The Francis Crick Institute and LifeArc partner with five African research…
Monday 14 August2023The Francis Crick Institute and LifeArc partner with five African research institutions to support scientists The Francis Crick institute and self-funded charitable medical research organisation , LifeArc, are partnering to invest £7.5m to support African scientists to address unmet medical needs in their communitiesThe Crick Africa Network launched in 2017 to help tackle infectious disease. The partnership between the Crick and five African...
Nasdaq GlobeNewswire
14/08/2023
XNK Therapeutics to present two posters at the NK2023 conference in Oslo in…
The data have been generated in collaboration with XNK's external partners, Anders Ullén and Fernanda Costa Svedman at the Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden, for the bladder cancer abstract, and Abhishek Maiti and Naval Daver at The University of Texas MD Anderson Cancer Center in Houston, Texas, USA, for the AML abstract. The data have been generated in collaboration with XNK's external partners, Anders Ullén andFernanda Costa Svedmanat the...
PR Newswire
14/08/2023
Xeltis secures additional €12.5 million from European Innovation Council Fund in…
Xeltissecures additional €12.5 million from European Innovation Council Fund infinal close of D2 financingFunding extends Xeltis' Series D2 financing round to €44.5 million EINDHOVEN, The Netherlands – 14 August 2023, Xeltis a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels today announces the closing of an additional €12.5 million in funding from the European Innovation Council (EIC) Fund, set up by the...
Nasdaq GlobeNewswire
14/08/2023
Exor becomes a long-term investor in Philips supporting the company's strategy
August 14, 2023 Joint announcement from Philips and Exor Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, and Exor N.V. (AEX: EXO), the Netherlands-based diversified holding company, announce they have entered into a relationship agreement as a result of which Exor has bought a 15% shareholding in Philips. This investment by Exor is fully supportive of Philips' leadership, strategy and value creation potential and provides...
Nasdaq GlobeNewswire
14/08/2023
Pharming Group to convene Extraordinary General Meeting of Shareholders
The agenda further includes the proposal to approve, by way of a supplement to the current Remuneration Policy for the Board of Directors, an increase in the annual fee payable to the Chair of the Board of Directors. The agenda further includes the proposal to approve, by way of a supplement to the current Remuneration Policy for the Board of Directors, an increase in the annual fee payable to the Chair of the Board of Directors. The EGM will be held as a physical meeting at Pharming's...
PR Newswire
14/08/2023
Valneva Announces PDUFA Date Extension for Chikungunya Virus Vaccine Candidate
Saint-Herblain(France), August14 , 2023–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has revised the Prescription Drug User Fee Act (PDUFA) action date for the Biologics License Application (BLA) for VLA1553, Valneva's chikungunya virus vaccine candidate, from the previously communicated end of August to the end of November. The FDA extended the PDUFA date to allow...
Nasdaq GlobeNewswire
14/08/2023
Novartis Completes Acquisition of Chinook Therapeutics
Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfrontDeal brings two phase 3 assets in development for IgAN; atrasentan, an oral endothelin A receptor antagonist, and zigakibart, an anti-APRIL monoclonal antibodyTransaction fully in line with Novartis strategy to focus on innovative medicines, significantly expands renal portfolio, complementing existing pipelineBasel, August 11, 2023— Novartis today announced...
Nasdaq GlobeNewswire
11/08/2023
US Healthcare Technology Management Market worth $17.3 billion |…
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3281026 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3281026 Browse in-depth TOC on "US Healthcare Technology Management Market" 25 - Tables 26 - Figures 110 - Pages US Healthcare Technology Management Market Scope: "The maintenance & repair segment accounted for the largest share of the market." Based on the...
PR Newswire
11/08/2023
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach
Throughout the program, EpiVax adapted in silico and in vitro immunogenicity risk assessment methods, previously leveraged for vaccine and biologics assessment, to evaluate the immunogenicity of generic drug impurities. The publication outlines EpiVax's recommended "PANDA" approach, featuring case studies. Throughout the program, EpiVax adapted in silico and in vitro immunogenicity risk assessment methods, previously leveraged for vaccine and biologics assessment, to evaluate the…
PR Newswire
11/08/2023
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…
Bagsværd, Denmark, 11August 2023— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members,...
Nasdaq GlobeNewswire
11/08/2023
IMC welcomes new Israeli cannabis regulations which are about to change…
Oncology, epilepsy, gastrointestinal diseases such as Crohn's and colitis, dementia, autism from the age of 5, multiple sclerosis, AIDS, Parkinsons, Tourette-Syndrome and palliative care. All Israeli patients suffering from these indications will be able to have access to medical cannabis with a regular prescription. The key aspects of the regulatory reform are the following: While point 1 is already approved, points 2 and 3 are pending final approval by the ministry of health...
PR Newswire
11/08/2023
Altri Comunicati
